In allogeneic patients, survival estimates highly correlated with bleeding intensity. The median survival in allogeneic minor bleeding was 10 months, 3.5 months in moderate, and 2.8 months in severe bleeding. The difference between NBLD and minor bleeding was not significant statistically (P = .089); a significant difference was found between minor versus moderate (P< .001) and between moderate versus severe bleeding (P= .025). NBLD, patients who did not bleed within 100 days after transplantation.